Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in the International Journal of Cancer, the IMPACT (IMproving Primary screening And Colposcopy … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Switzerland, Technology
Tagged biomarker, cervical cancer, cervical cells, cervical pre-cancers, CINtec PLUS Cytology, Colposcopy Triage, HPV, HPV-positive women, human papillomavirus, impact, International Journal of Cancer, Pap cytology, Roche, testing
LEEDS, 03-May-2018 — /EuropaWire/ — New drugs in the early stages of development by pharmaceutical companies could have an extra benefit – the ability to cancel out HPV virus, which can cause cervical cancer and skin conditions. Scientists at the … Read the full press release
Posted in Education, Healthcare, Science, Technology, United Kingdom
Tagged Cancer, Dr Andrew Macdonald, Ethan Morgan, HPV, Human Papilloma Virus, Papilloma, proteins, STAT3, University of Birmingham, University of Leeds
4-6-2013 — /europawire.eu/ — Scientists at the University of Leeds have found a way to target and destroy a key protein associated with the development of cervical and other cancers. The E7 protein is produced early in the lifecycle of the … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged Aptamers, BBSRC, Cancer, carcinogenic protein, cervical cancer, Dr Nicola Stonehouse, E7 protein, HPV, HPV positive, human papillomavirus, molecule, papillomavirus, RNA aptamer, RNA aptamers, scientists, University of Leeds, virus infection, Yorkshire Cancer Research
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
